Actuate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancers in the United States. The company’s lead product candidate is elraglusib ...

Coalition seizes on Michele O’Neil’s comments, claiming they send a ‘confusing signal’ on $368bn nuclear submarine acquisition Australian unions have restated their position in favour of a ...

) has been revised to $17.85 / share. This is a decrease of 15.66% from the prior estimate of $21.16 dated April 25, 2026. The price target is an average of many targets provided by analysts. The ...

We see their spokespeople quoted in the papers and their ads on TV, but beyond that we know very little about how Australia’s lobby groups get what they want. This series shines a light on the ...

Actuate Therapeutics, Inc. (ACTU) closed the last trading session at $6.9, gaining 4.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set ...

Unionist quits ACTU after five years as secretary, saying he wants to spend more time with his family Dave Oliver has announced his resignation as secretary of the ACTU after five years in the post, ...

) has been revised to $21.16 / share. This is a decrease of 17.00% from the prior estimate of $25.50 dated April 12, 2026. The price target is an average of many targets provided by analysts. The ...

The Australian Council of Trade Unions (ACTU) released a statement Monday, pointing to the critical role of Australian companies in the global weapons business and calling on the federal Labor ...

Standing before a sea of rainbow flags at a rally for same-sex marriage, Sally McManus leans in on a stairway rail and points out signs in the crowd. Taking the microphone as one of the key speakers ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

We see their spokespeople quoted in the papers and their ads on TV, but beyond that we know very little about how Australia’s lobby groups get what they want. This series shines a light on the ...